These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22836204)

  • 21. Association of European population levels of thrombotic and inflammatory factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study.
    Yarnell J; McCrum E; Rumley A; Patterson C; Salomaa V; Lowe G; Evans A
    Eur Heart J; 2005 Feb; 26(4):332-42; discussion 317-8. PubMed ID: 15618045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vampire bat salivary plasminogen activator promotes robust lysis of plasma clots in a plasma milieu without causing fluid phase plasminogen activation.
    Hare TR; Gardell SJ
    Thromb Haemost; 1992 Aug; 68(2):165-9. PubMed ID: 1412162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heritability of clot formation, morphology, and lysis: the EuroCLOT study.
    Carter AM; Cymbalista CM; Spector TD; Grant PJ;
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2783-9. PubMed ID: 17932316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the metabolic syndrome with PAI 1
    Swanepoel AC; van Reenen M; de Lange-Loots Z; Pieters M
    Nutr Metab Cardiovasc Dis; 2023 Mar; 33(3):592-601. PubMed ID: 36646603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
    Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia.
    Nowakowski T; Malinowski KP; Niżankowski R; Iwaniec T; Undas A
    J Thromb Thrombolysis; 2019 May; 47(4):540-549. PubMed ID: 30762155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.
    Meltzer ME; Hasstedt SJ; Vossen CY; Callas PW; DE Groot PG; Rosendaal FR; Lisman T; Bovill EG
    J Thromb Haemost; 2011 Jul; 9(7):1383-90. PubMed ID: 21575129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W; Anders E; Binder BR; Müller-Berghaus G
    Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
    Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
    Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
    MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
    Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
    J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).
    Gajos G; Zalewski J; Rostoff P; Nessler J; Piwowarska W; Undas A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1696-702. PubMed ID: 21617138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
    ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
    Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation.
    Leaker MT; Brooker LA; Mitchell LG; Weitz JI; Superina R; Andrew ME
    Transplantation; 1995 Jul; 60(2):144-7. PubMed ID: 7624956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of selected prothrombotic and proinflammatory factors on the incidence of venous thrombosis after pacemaker implantation.
    Lelakowski J; Domagała TB; Rydlewska A; Januszek R; Kotula Horowitz K; Majewski J; Ząbek A; Małecka B; Musiał J
    Kardiol Pol; 2012; 70(3):260-7. PubMed ID: 22430407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.